Virtual trials became a necessity during the COVID-19 pandemic. The clinical research industry suffered mass disruption as a result (i.e., site closures & costly delays). Fortunately, ObvioHealth had been designing and conducting fully virtual and decentralized studies well the pandemic. Our presentation recaps lessons learned from 4+ years and 35+ decentralized clinical trials.
Interested in Viewing our Presentation?
Fill out the form below for access.
Preview the Webinar Below:
ObvioHealth studies are run on our purpose-built platform by our own in-house virtual team. This allows us to work seamlessly from protocol design all the way through to analysis and reporting.
Up to 4x
3 mo ObvioHealth average vs 12 mo benchmark for site-based trials
average retention vs. 70% benchmark for traditional trials
average per study (digital questionnaires, daily ediary, etc.).